Outcomes4Me

🌎 Aligning with World Health Day's theme of "Healthy beginnings, hopeful futures," we've compiled a few fertility preservation resources and strategies for women looking to protect their fertility in the face of cancer. Read the blog here: https://bit.ly/3G6bY8T #fertility #maternalhealth #worldhealthday2025 #whd25 #cancercare #cancersupport #digitalhealth #patientempowerment #patientadvocate #oncology

If you're a patient, survivor, caregiver, or nurse in the Denver area, our partner CURE® is hosting its latest Educated Patient® Update on Tuesday, April 15th at the Rocky Mountain Cancer Centers! Register here 👉 https://bit.ly/4lbolAR Join this free event and hear from two esteemed oncologists on the latest treatment advances for metastatic breast cancer. Don't miss the opportunity to connect with the community and engage with experts in the field. #mbc #ESR1 #metastaticbreastcancer #patientempowerment #patientnavigation #canceradvocacy #breastcancer #digitalhealth

📣 Outcomes4Me is one of the fastest-growing companies in the Northeast, according to Inc. Magazine! ✨ We jumped from #70 last year to #12 on the 2025 #IncRegionals Northeast list. Our growth for the awards time period was 479%! Business success for us means we’re able to reinvest into our platform that serves patients with cancer (at no cost to them) & continue to innovate, which is why this recognition of our growth is so gratifying. Learn more about the 2025 list here: https://lnkd.in/dHXx2a_B #IncRegionals #HealthTech #TechAI #DigitalHealth #CancerCare

At Outcomes4Me, we aim to empower every patient with cancer with the latest, evidence-based clinical guidance to help them feel informed, supported, and confident in their healthcare decisions from diagnosis to active treatment and beyond. #Patientsfirst #PatientEmpowerment #CancerSupport #Oncology #DigitalHealth

🖥️ Our webinar recording on integrative oncology with City of Hope's Dr. Krisstina Gowin is now available! Watch it here: https://bit.ly/4hKkwzx Tune in for an insightful discussion on: ✅ Nutrition and exercise ✅ Acupuncture ✅ Mind-body techniques ✅ And more #Integrativeoncology #cancersupport #mentalhealth #qualityoflife #oncologycare #mindfulness

"The Promise and Pitfalls of Artificial Intelligence in Cancer Care." Our Founder and CEO Dr. Maya Said will address this topic as a speaker at tomorrow's National Coalition for Cancer Survivorship Spring 2025 Cancer Policy Roundtable, taking place in Washington, D.C. Along with her fellow panelists, Maya will explore how patients, caregivers, and advocates can use AI to benefit patients. They'll also discuss the safeguards necessary to use "AI for good" in cancer care. We're looking forward to Maya sharing how Outcomes4Me uses AI to help ensure that every patient living with cancer has access to the latest, evidence-based clinical guidance and the chance for the very best health outcomes. Learn more about NCCS: https://lnkd.in/grGRSgdG #NCCS #CPR25 #AIinCancerCare #patientnavigation #oncologycare

Our discussion with Fred Hutch Cancer Center's Dr. Sara Hurvitz is now available 👉 https://lnkd.in/eiMYmMW6 Watch the recording to better understand the roles of tests including Oncotype DX, MammaPrint, FoundationOne, and more. #PatientNavigation #BreastCancer #CancerSupport #DigitalHealth #PatientEmpowerment

Side effects from cancer treatment on top of anxiety and stress can contribute to sleep issues. Here are 5 strategies that can help ➡️ https://lnkd.in/eAx9w5k2 #DigitalHealth #CancerCare #OncologySupport #WorldSleepDay2025

📢 Today, we announce another partnership that supports our patients-first value and our goal of ensuring that all people living with cancer have the evidence-based information they need to make the best decisions about their own care. Through our joint efforts with Biovica International AB, we're working to inform patients with HR-positive metastatic breast cancer, currently on a CDK 4/6 inhibitor, about Biovica’s DiviTum® TKa test. This is a blood-based biomarker test that clinicians can rely upon to assess proliferation changes in their HR-positive, mBC patients’ tumor cells months before imaging can detect a tumor volume increase. Because every patient deserves to understand as soon as possible if their treatment protocol may no longer be working. Learn more in the press release: https://lnkd.in/e8_TF9wY #digitalhealth #oncologycare #patientempowerment #cancertreatmentoptions #CDK46inhibitors #mBC #bloodbiomarkertest #patientnavigation #patienteducation #precisiononcology #personalizedmedicine

📢 Today, we announce another partnership that supports our patients-first value and our goal of ensuring that all people living with cancer have the evidence-based information they need to make the best decisions about their own care. Through our joint efforts with Biovica International AB, we're working to inform patients with HR-positive metastatic breast cancer, currently on a CDK 4/6 inhibitor, about Biovica’s DiviTum® TKa test. This is a blood-based biomarker test that clinicians can rely upon to assess proliferation changes in their HR-positive, mBC patients’ tumor cells months before imaging can detect a tumor volume increase. Because every patient deserves to understand as soon as possible if their treatment protocol may no longer be working. Learn more in the press release: https://lnkd.in/e8_TF9wY #digitalhealth #oncologycare #patientempowerment #cancertreatmentoptions #CDK46inhibitors #mBC #bloodbiomarkertest #patientnavigation #patienteducation #precisiononcology #personalizedmedicine